These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23536547)

  • 1. Discovering new medicines targeting helicases: challenges and recent progress.
    Shadrick WR; Ndjomou J; Kolli R; Mukherjee S; Hanson AM; Frick DN
    J Biomol Screen; 2013 Aug; 18(7):761-81. PubMed ID: 23536547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding helicases as a means of virus control.
    Frick DN; Lam AM
    Curr Pharm Des; 2006; 12(11):1315-38. PubMed ID: 16611118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
    Kukhanova MK; Karpenko IL; Ivanov AV
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicases as antiviral and anticancer drug targets.
    Xi XG
    Curr Med Chem; 2007; 14(8):883-915. PubMed ID: 17430143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.
    Field HJ; Biswas S
    Drug Resist Updat; 2011 Feb; 14(1):45-51. PubMed ID: 21183396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicases as antiviral drug targets.
    Frick DN
    Drug News Perspect; 2003; 16(6):355-62. PubMed ID: 12973446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicase primase: targeting the Achilles heel of herpes simplex viruses.
    Kleymann G
    Antivir Chem Chemother; 2004 May; 15(3):135-40. PubMed ID: 15266895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA helicases as targets for anti-cancer drugs.
    Sharma S; Doherty KM; Brosh RM
    Curr Med Chem Anticancer Agents; 2005 May; 5(3):183-99. PubMed ID: 15992349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs.
    Bazhulina NP; Surovaya AN; Gursky YG; Andronova VL; Moiseeva ED; Nikitin CA; Golovkin MV; Galegov GА; Grokhovsky SL; Gursky GV
    J Biomol Struct Dyn; 2014; 32(9):1456-73. PubMed ID: 23879454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA helicase, ATPase and DNA-binding activities of E. coli RecQ helicase by chemotherapeutic agents.
    Zhang B; Zhang AH; Chen L; Xi XG
    J Biochem; 2008 Jun; 143(6):773-9. PubMed ID: 18296713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of BKV large T-antigen ATP-binding site as a target for drug discovery.
    Zeng G; Bueno M; Camachos CJ; Ramaswami B; Luo C; Randhawa P
    Antiviral Res; 2009 Feb; 81(2):184-7. PubMed ID: 19084558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.
    Biswas S; Sukla S; Field HJ
    Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short commentary on the review by Weller and Kuchta: the DNA helicase-primase complex as a target for herpes virus infection.
    Field HJ
    Expert Opin Ther Targets; 2013 Oct; 17(10):1113-4. PubMed ID: 24044544
    [No Abstract]   [Full Text] [Related]  

  • 16. UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance.
    Muylaert I; Zhao Z; Elias P
    J Biol Chem; 2014 Nov; 289(47):32583-92. PubMed ID: 25278021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.
    Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D
    Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role reversal of functional identity in host factors: Dissecting features affecting pro-viral versus antiviral functions of cellular DEAD-box helicases in tombusvirus replication.
    Wu CY; Nagy PD
    PLoS Pathog; 2020 Oct; 16(10):e1008990. PubMed ID: 33035275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
    Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
    J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit.
    Li B; Pai R; Aiello D; Di M; Barnes MH; Peet NP; Bowlin TL; Moir DT
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3481-6. PubMed ID: 23664213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.